qx-314 has been researched along with ranolazine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ackerman, MJ; Bernard, CE; Beyder, A; Farrugia, G; Makielski, J; Reyes, S; Strege, PR; Terzic, A | 1 |
Ahern, CA; Goodchild, SJ; Lee, S | 1 |
2 other study(ies) available for qx-314 and ranolazine
Article | Year |
---|---|
Ranolazine decreases mechanosensitivity of the voltage-gated sodium ion channel Na(v)1.5: a novel mechanism of drug action.
Topics: Acetanilides; Animals; Biomechanical Phenomena; Cells, Cultured; Enzyme Inhibitors; HEK293 Cells; Humans; Kidney; Lidocaine; Mice; Mice, Inbred C57BL; Models, Animal; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Patch-Clamp Techniques; Piperazines; Ranolazine; Sodium Channels; Transfection | 2012 |
Local anesthetic inhibition of a bacterial sodium channel.
Topics: Acetanilides; Anesthetics, Local; Bacillus; Benzocaine; Binding Sites; Cell Line, Transformed; Cytoplasm; Eukaryota; HEK293 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Ion Channel Gating; Kinetics; Lidocaine; Piperazines; Ranolazine; Sodium; Sodium Channels | 2012 |